Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by skier59on Nov 26, 2020 7:33am
163 Views
Post# 31977055

RE:RE:RE:to launch 4 to 5 clinical study sites in USA 4Q2020

RE:RE:RE:to launch 4 to 5 clinical study sites in USA 4Q2020Yup I've said this before, the FDA can grant approval of a drug if it's study and subsequent approval is achieved in another country such as Canada. We actually don't need, although would only be a positive, study conducted in the USA. But, as I've said, let's not let this COVID situation slow us down anymore and get that 24 bottled up in Canada ASAP.



floatinketucky wrote: Clearly the FDA is accepting Data points on Canadian patients. We could see the bulk of patients treated in Canada. Perhaps we should expect this. 


<< Previous
Bullboard Posts
Next >>